nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0884	0.248	CbGbCtD
Everolimus—CYP3A4—Triamcinolone—psoriatic arthritis	0.067	0.188	CbGbCtD
Everolimus—CYP3A4—Betamethasone—psoriatic arthritis	0.0574	0.161	CbGbCtD
Everolimus—CYP3A4—Prednisolone—psoriatic arthritis	0.0567	0.159	CbGbCtD
Everolimus—CYP3A4—Prednisone—psoriatic arthritis	0.0535	0.15	CbGbCtD
Everolimus—CYP3A4—Dexamethasone—psoriatic arthritis	0.0334	0.0938	CbGbCtD
Everolimus—Stomatitis—Methotrexate—psoriatic arthritis	0.000432	0.000672	CcSEcCtD
Everolimus—Angiopathy—Prednisone—psoriatic arthritis	0.000432	0.000672	CcSEcCtD
Everolimus—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000431	0.00067	CcSEcCtD
Everolimus—Immune system disorder—Prednisone—psoriatic arthritis	0.00043	0.000669	CcSEcCtD
Everolimus—Malaise—Betamethasone—psoriatic arthritis	0.00043	0.000667	CcSEcCtD
Everolimus—Malaise—Dexamethasone—psoriatic arthritis	0.00043	0.000667	CcSEcCtD
Everolimus—Oedema—Triamcinolone—psoriatic arthritis	0.000428	0.000666	CcSEcCtD
Everolimus—Syncope—Dexamethasone—psoriatic arthritis	0.000427	0.000664	CcSEcCtD
Everolimus—Syncope—Betamethasone—psoriatic arthritis	0.000427	0.000664	CcSEcCtD
Everolimus—Infection—Triamcinolone—psoriatic arthritis	0.000426	0.000661	CcSEcCtD
Everolimus—Infection—Methylprednisolone—psoriatic arthritis	0.000425	0.00066	CcSEcCtD
Everolimus—Haematuria—Methotrexate—psoriatic arthritis	0.000423	0.000657	CcSEcCtD
Everolimus—Shock—Triamcinolone—psoriatic arthritis	0.000421	0.000655	CcSEcCtD
Everolimus—Insomnia—Prednisolone—psoriatic arthritis	0.000421	0.000655	CcSEcCtD
Everolimus—Alopecia—Prednisone—psoriatic arthritis	0.000421	0.000654	CcSEcCtD
Everolimus—Shock—Methylprednisolone—psoriatic arthritis	0.000421	0.000653	CcSEcCtD
Everolimus—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00042	0.000652	CcSEcCtD
Everolimus—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000419	0.000651	CcSEcCtD
Everolimus—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000419	0.00065	CcSEcCtD
Everolimus—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000419	0.00065	CcSEcCtD
Everolimus—Epistaxis—Methotrexate—psoriatic arthritis	0.000418	0.00065	CcSEcCtD
Everolimus—Paraesthesia—Prednisolone—psoriatic arthritis	0.000418	0.00065	CcSEcCtD
Everolimus—Tachycardia—Triamcinolone—psoriatic arthritis	0.000418	0.00065	CcSEcCtD
Everolimus—Mental disorder—Prednisone—psoriatic arthritis	0.000417	0.000649	CcSEcCtD
Everolimus—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000417	0.000648	CcSEcCtD
Everolimus—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000415	0.000645	CcSEcCtD
Everolimus—Malnutrition—Prednisone—psoriatic arthritis	0.000415	0.000644	CcSEcCtD
Everolimus—Erythema—Prednisone—psoriatic arthritis	0.000415	0.000644	CcSEcCtD
Everolimus—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000414	0.000644	CcSEcCtD
Everolimus—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000413	0.000642	CcSEcCtD
Everolimus—Convulsion—Betamethasone—psoriatic arthritis	0.000413	0.000641	CcSEcCtD
Everolimus—Convulsion—Dexamethasone—psoriatic arthritis	0.000413	0.000641	CcSEcCtD
Everolimus—Hypertension—Betamethasone—psoriatic arthritis	0.000411	0.000639	CcSEcCtD
Everolimus—Hypertension—Dexamethasone—psoriatic arthritis	0.000411	0.000639	CcSEcCtD
Everolimus—Myalgia—Betamethasone—psoriatic arthritis	0.000405	0.00063	CcSEcCtD
Everolimus—Myalgia—Dexamethasone—psoriatic arthritis	0.000405	0.00063	CcSEcCtD
Everolimus—Anxiety—Dexamethasone—psoriatic arthritis	0.000404	0.000628	CcSEcCtD
Everolimus—Anxiety—Betamethasone—psoriatic arthritis	0.000404	0.000628	CcSEcCtD
Everolimus—Discomfort—Dexamethasone—psoriatic arthritis	0.000401	0.000623	CcSEcCtD
Everolimus—Discomfort—Betamethasone—psoriatic arthritis	0.000401	0.000623	CcSEcCtD
Everolimus—Haemoglobin—Methotrexate—psoriatic arthritis	0.0004	0.000622	CcSEcCtD
Everolimus—Hypotension—Methylprednisolone—psoriatic arthritis	0.000399	0.000621	CcSEcCtD
Everolimus—Pain—Prednisolone—psoriatic arthritis	0.000398	0.000619	CcSEcCtD
Everolimus—Haemorrhage—Methotrexate—psoriatic arthritis	0.000398	0.000619	CcSEcCtD
Everolimus—Hepatitis—Methotrexate—psoriatic arthritis	0.000398	0.000619	CcSEcCtD
Everolimus—Pharyngitis—Methotrexate—psoriatic arthritis	0.000395	0.000614	CcSEcCtD
Everolimus—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000393	0.000611	CcSEcCtD
Everolimus—Vision blurred—Prednisone—psoriatic arthritis	0.000391	0.000607	CcSEcCtD
Everolimus—Urethral disorder—Methotrexate—psoriatic arthritis	0.00039	0.000607	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00039	0.000606	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000389	0.000605	CcSEcCtD
Everolimus—Oedema—Dexamethasone—psoriatic arthritis	0.000389	0.000604	CcSEcCtD
Everolimus—Oedema—Betamethasone—psoriatic arthritis	0.000389	0.000604	CcSEcCtD
Everolimus—Insomnia—Triamcinolone—psoriatic arthritis	0.000387	0.000602	CcSEcCtD
Everolimus—Insomnia—Methylprednisolone—psoriatic arthritis	0.000387	0.000601	CcSEcCtD
Everolimus—Infection—Dexamethasone—psoriatic arthritis	0.000386	0.0006	CcSEcCtD
Everolimus—Infection—Betamethasone—psoriatic arthritis	0.000386	0.0006	CcSEcCtD
Everolimus—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000385	0.000598	CcSEcCtD
Everolimus—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000385	0.000598	CcSEcCtD
Everolimus—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000384	0.000596	CcSEcCtD
Everolimus—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000384	0.000596	CcSEcCtD
Everolimus—Anaemia—Prednisone—psoriatic arthritis	0.000383	0.000596	CcSEcCtD
Everolimus—Shock—Dexamethasone—psoriatic arthritis	0.000382	0.000594	CcSEcCtD
Everolimus—Shock—Betamethasone—psoriatic arthritis	0.000382	0.000594	CcSEcCtD
Everolimus—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000382	0.000593	CcSEcCtD
Everolimus—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000381	0.000592	CcSEcCtD
Everolimus—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000381	0.000592	CcSEcCtD
Everolimus—Agitation—Prednisone—psoriatic arthritis	0.000381	0.000592	CcSEcCtD
Everolimus—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000381	0.000591	CcSEcCtD
Everolimus—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000381	0.000591	CcSEcCtD
Everolimus—Tachycardia—Dexamethasone—psoriatic arthritis	0.000379	0.000589	CcSEcCtD
Everolimus—Tachycardia—Betamethasone—psoriatic arthritis	0.000379	0.000589	CcSEcCtD
Everolimus—Angioedema—Prednisone—psoriatic arthritis	0.000379	0.000589	CcSEcCtD
Everolimus—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000377	0.000586	CcSEcCtD
Everolimus—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000376	0.000585	CcSEcCtD
Everolimus—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000376	0.000584	CcSEcCtD
Everolimus—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000376	0.000584	CcSEcCtD
Everolimus—Malaise—Prednisone—psoriatic arthritis	0.000374	0.000581	CcSEcCtD
Everolimus—Eye disorder—Methotrexate—psoriatic arthritis	0.000372	0.000578	CcSEcCtD
Everolimus—Syncope—Prednisone—psoriatic arthritis	0.000372	0.000578	CcSEcCtD
Everolimus—Anorexia—Dexamethasone—psoriatic arthritis	0.000371	0.000576	CcSEcCtD
Everolimus—Anorexia—Betamethasone—psoriatic arthritis	0.000371	0.000576	CcSEcCtD
Everolimus—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00037	0.000574	CcSEcCtD
Everolimus—Fatigue—Triamcinolone—psoriatic arthritis	0.000369	0.000574	CcSEcCtD
Everolimus—Fatigue—Methylprednisolone—psoriatic arthritis	0.000369	0.000573	CcSEcCtD
Everolimus—Pain—Triamcinolone—psoriatic arthritis	0.000366	0.000569	CcSEcCtD
Everolimus—Loss of consciousness—Prednisone—psoriatic arthritis	0.000365	0.000566	CcSEcCtD
Everolimus—Hypotension—Dexamethasone—psoriatic arthritis	0.000363	0.000564	CcSEcCtD
Everolimus—Hypotension—Betamethasone—psoriatic arthritis	0.000363	0.000564	CcSEcCtD
Everolimus—Angiopathy—Methotrexate—psoriatic arthritis	0.000361	0.000561	CcSEcCtD
Everolimus—Immune system disorder—Methotrexate—psoriatic arthritis	0.00036	0.000559	CcSEcCtD
Everolimus—Convulsion—Prednisone—psoriatic arthritis	0.000359	0.000558	CcSEcCtD
Everolimus—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000359	0.000558	CcSEcCtD
Everolimus—Hypertension—Prednisone—psoriatic arthritis	0.000358	0.000556	CcSEcCtD
Everolimus—Chills—Methotrexate—psoriatic arthritis	0.000357	0.000555	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000354	0.00055	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000354	0.00055	CcSEcCtD
Everolimus—Arthralgia—Prednisone—psoriatic arthritis	0.000353	0.000549	CcSEcCtD
Everolimus—Myalgia—Prednisone—psoriatic arthritis	0.000353	0.000549	CcSEcCtD
Everolimus—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000353	0.000549	CcSEcCtD
Everolimus—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000352	0.000547	CcSEcCtD
Everolimus—Anxiety—Prednisone—psoriatic arthritis	0.000352	0.000547	CcSEcCtD
Everolimus—Alopecia—Methotrexate—psoriatic arthritis	0.000352	0.000547	CcSEcCtD
Everolimus—Insomnia—Betamethasone—psoriatic arthritis	0.000352	0.000546	CcSEcCtD
Everolimus—Insomnia—Dexamethasone—psoriatic arthritis	0.000352	0.000546	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000351	0.000545	CcSEcCtD
Everolimus—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00035	0.000543	CcSEcCtD
Everolimus—Paraesthesia—Betamethasone—psoriatic arthritis	0.000349	0.000542	CcSEcCtD
Everolimus—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000349	0.000542	CcSEcCtD
Everolimus—Discomfort—Prednisone—psoriatic arthritis	0.000349	0.000542	CcSEcCtD
Everolimus—Mental disorder—Methotrexate—psoriatic arthritis	0.000349	0.000542	CcSEcCtD
Everolimus—Malnutrition—Methotrexate—psoriatic arthritis	0.000347	0.000539	CcSEcCtD
Everolimus—Erythema—Methotrexate—psoriatic arthritis	0.000347	0.000539	CcSEcCtD
Everolimus—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000343	0.000533	CcSEcCtD
Everolimus—Dyspepsia—Betamethasone—psoriatic arthritis	0.000342	0.000532	CcSEcCtD
Everolimus—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000342	0.000532	CcSEcCtD
Everolimus—Dysgeusia—Methotrexate—psoriatic arthritis	0.000339	0.000527	CcSEcCtD
Everolimus—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000339	0.000526	CcSEcCtD
Everolimus—Oedema—Prednisone—psoriatic arthritis	0.000339	0.000526	CcSEcCtD
Everolimus—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000338	0.000525	CcSEcCtD
Everolimus—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000338	0.000525	CcSEcCtD
Everolimus—Decreased appetite—Betamethasone—psoriatic arthritis	0.000338	0.000525	CcSEcCtD
Everolimus—Infection—Prednisone—psoriatic arthritis	0.000336	0.000523	CcSEcCtD
Everolimus—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000336	0.000521	CcSEcCtD
Everolimus—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000336	0.000521	CcSEcCtD
Everolimus—Back pain—Methotrexate—psoriatic arthritis	0.000335	0.000521	CcSEcCtD
Everolimus—Fatigue—Dexamethasone—psoriatic arthritis	0.000335	0.000521	CcSEcCtD
Everolimus—Fatigue—Betamethasone—psoriatic arthritis	0.000335	0.000521	CcSEcCtD
Everolimus—Shock—Prednisone—psoriatic arthritis	0.000333	0.000517	CcSEcCtD
Everolimus—Pain—Dexamethasone—psoriatic arthritis	0.000332	0.000517	CcSEcCtD
Everolimus—Pain—Betamethasone—psoriatic arthritis	0.000332	0.000517	CcSEcCtD
Everolimus—Nervous system disorder—Prednisone—psoriatic arthritis	0.000332	0.000516	CcSEcCtD
Everolimus—Tachycardia—Prednisone—psoriatic arthritis	0.00033	0.000513	CcSEcCtD
Everolimus—Skin disorder—Prednisone—psoriatic arthritis	0.000329	0.000511	CcSEcCtD
Everolimus—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000327	0.000508	CcSEcCtD
Everolimus—Vision blurred—Methotrexate—psoriatic arthritis	0.000327	0.000508	CcSEcCtD
Everolimus—Anorexia—Prednisone—psoriatic arthritis	0.000323	0.000501	CcSEcCtD
Everolimus—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000322	0.0005	CcSEcCtD
Everolimus—Anaemia—Methotrexate—psoriatic arthritis	0.00032	0.000498	CcSEcCtD
Everolimus—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00032	0.000498	CcSEcCtD
Everolimus—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00032	0.000498	CcSEcCtD
Everolimus—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000318	0.000494	CcSEcCtD
Everolimus—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000318	0.000494	CcSEcCtD
Everolimus—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000316	0.00049	CcSEcCtD
Everolimus—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000315	0.000489	CcSEcCtD
Everolimus—Malaise—Methotrexate—psoriatic arthritis	0.000313	0.000486	CcSEcCtD
Everolimus—Leukopenia—Methotrexate—psoriatic arthritis	0.00031	0.000482	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000308	0.000479	CcSEcCtD
Everolimus—Dizziness—Prednisolone—psoriatic arthritis	0.000308	0.000479	CcSEcCtD
Everolimus—Asthenia—Triamcinolone—psoriatic arthritis	0.000307	0.000478	CcSEcCtD
Everolimus—Body temperature increased—Betamethasone—psoriatic arthritis	0.000307	0.000477	CcSEcCtD
Everolimus—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000307	0.000477	CcSEcCtD
Everolimus—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000307	0.000477	CcSEcCtD
Everolimus—Abdominal pain—Betamethasone—psoriatic arthritis	0.000307	0.000477	CcSEcCtD
Everolimus—Asthenia—Methylprednisolone—psoriatic arthritis	0.000307	0.000477	CcSEcCtD
Everolimus—Insomnia—Prednisone—psoriatic arthritis	0.000306	0.000476	CcSEcCtD
Everolimus—Paraesthesia—Prednisone—psoriatic arthritis	0.000304	0.000472	CcSEcCtD
Everolimus—Pruritus—Triamcinolone—psoriatic arthritis	0.000303	0.000471	CcSEcCtD
Everolimus—Cough—Methotrexate—psoriatic arthritis	0.000302	0.00047	CcSEcCtD
Everolimus—Pruritus—Methylprednisolone—psoriatic arthritis	0.000302	0.00047	CcSEcCtD
Everolimus—Convulsion—Methotrexate—psoriatic arthritis	0.0003	0.000467	CcSEcCtD
Everolimus—Dyspepsia—Prednisone—psoriatic arthritis	0.000298	0.000463	CcSEcCtD
Everolimus—Chest pain—Methotrexate—psoriatic arthritis	0.000295	0.000459	CcSEcCtD
Everolimus—Arthralgia—Methotrexate—psoriatic arthritis	0.000295	0.000459	CcSEcCtD
Everolimus—Myalgia—Methotrexate—psoriatic arthritis	0.000295	0.000459	CcSEcCtD
Everolimus—Decreased appetite—Prednisone—psoriatic arthritis	0.000294	0.000457	CcSEcCtD
Everolimus—Rash—Prednisolone—psoriatic arthritis	0.000294	0.000456	CcSEcCtD
Everolimus—Dermatitis—Prednisolone—psoriatic arthritis	0.000293	0.000456	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000293	0.000455	CcSEcCtD
Everolimus—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000292	0.000454	CcSEcCtD
Everolimus—Fatigue—Prednisone—psoriatic arthritis	0.000292	0.000453	CcSEcCtD
Everolimus—Headache—Prednisolone—psoriatic arthritis	0.000292	0.000453	CcSEcCtD
Everolimus—Discomfort—Methotrexate—psoriatic arthritis	0.000292	0.000453	CcSEcCtD
Everolimus—Constipation—Prednisone—psoriatic arthritis	0.000289	0.00045	CcSEcCtD
Everolimus—Dizziness—Triamcinolone—psoriatic arthritis	0.000283	0.00044	CcSEcCtD
Everolimus—Dizziness—Methylprednisolone—psoriatic arthritis	0.000283	0.000439	CcSEcCtD
Everolimus—Infection—Methotrexate—psoriatic arthritis	0.000281	0.000437	CcSEcCtD
Everolimus—Feeling abnormal—Prednisone—psoriatic arthritis	0.000279	0.000433	CcSEcCtD
Everolimus—Asthenia—Betamethasone—psoriatic arthritis	0.000279	0.000433	CcSEcCtD
Everolimus—Asthenia—Dexamethasone—psoriatic arthritis	0.000279	0.000433	CcSEcCtD
Everolimus—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000277	0.000431	CcSEcCtD
Everolimus—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000277	0.00043	CcSEcCtD
Everolimus—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000277	0.00043	CcSEcCtD
Everolimus—Nausea—Prednisolone—psoriatic arthritis	0.000277	0.00043	CcSEcCtD
Everolimus—Pruritus—Betamethasone—psoriatic arthritis	0.000275	0.000427	CcSEcCtD
Everolimus—Pruritus—Dexamethasone—psoriatic arthritis	0.000275	0.000427	CcSEcCtD
Everolimus—Skin disorder—Methotrexate—psoriatic arthritis	0.000275	0.000427	CcSEcCtD
Everolimus—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000273	0.000425	CcSEcCtD
Everolimus—Vomiting—Triamcinolone—psoriatic arthritis	0.000272	0.000423	CcSEcCtD
Everolimus—Vomiting—Methylprednisolone—psoriatic arthritis	0.000272	0.000422	CcSEcCtD
Everolimus—Rash—Triamcinolone—psoriatic arthritis	0.00027	0.00042	CcSEcCtD
Everolimus—Dermatitis—Triamcinolone—psoriatic arthritis	0.00027	0.000419	CcSEcCtD
Everolimus—Anorexia—Methotrexate—psoriatic arthritis	0.00027	0.000419	CcSEcCtD
Everolimus—Rash—Methylprednisolone—psoriatic arthritis	0.00027	0.000419	CcSEcCtD
Everolimus—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000269	0.000418	CcSEcCtD
Everolimus—Headache—Triamcinolone—psoriatic arthritis	0.000268	0.000417	CcSEcCtD
Everolimus—Headache—Methylprednisolone—psoriatic arthritis	0.000268	0.000416	CcSEcCtD
Everolimus—Body temperature increased—Prednisone—psoriatic arthritis	0.000268	0.000416	CcSEcCtD
Everolimus—Abdominal pain—Prednisone—psoriatic arthritis	0.000268	0.000416	CcSEcCtD
Everolimus—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000266	0.000413	CcSEcCtD
Everolimus—Diarrhoea—Betamethasone—psoriatic arthritis	0.000266	0.000413	CcSEcCtD
Everolimus—Hypotension—Methotrexate—psoriatic arthritis	0.000264	0.000411	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000258	0.000401	CcSEcCtD
Everolimus—Dizziness—Dexamethasone—psoriatic arthritis	0.000257	0.000399	CcSEcCtD
Everolimus—Dizziness—Betamethasone—psoriatic arthritis	0.000257	0.000399	CcSEcCtD
Everolimus—Insomnia—Methotrexate—psoriatic arthritis	0.000256	0.000398	CcSEcCtD
Everolimus—Nausea—Triamcinolone—psoriatic arthritis	0.000254	0.000395	CcSEcCtD
Everolimus—Paraesthesia—Methotrexate—psoriatic arthritis	0.000254	0.000395	CcSEcCtD
Everolimus—Nausea—Methylprednisolone—psoriatic arthritis	0.000254	0.000395	CcSEcCtD
Everolimus—Dyspnoea—Methotrexate—psoriatic arthritis	0.000252	0.000392	CcSEcCtD
Everolimus—Somnolence—Methotrexate—psoriatic arthritis	0.000252	0.000391	CcSEcCtD
Everolimus—Hypersensitivity—Prednisone—psoriatic arthritis	0.000249	0.000388	CcSEcCtD
Everolimus—Dyspepsia—Methotrexate—psoriatic arthritis	0.000249	0.000387	CcSEcCtD
Everolimus—Vomiting—Dexamethasone—psoriatic arthritis	0.000247	0.000384	CcSEcCtD
Everolimus—Vomiting—Betamethasone—psoriatic arthritis	0.000247	0.000384	CcSEcCtD
Everolimus—Decreased appetite—Methotrexate—psoriatic arthritis	0.000246	0.000382	CcSEcCtD
Everolimus—Rash—Dexamethasone—psoriatic arthritis	0.000245	0.000381	CcSEcCtD
Everolimus—Rash—Betamethasone—psoriatic arthritis	0.000245	0.000381	CcSEcCtD
Everolimus—Dermatitis—Betamethasone—psoriatic arthritis	0.000245	0.00038	CcSEcCtD
Everolimus—Dermatitis—Dexamethasone—psoriatic arthritis	0.000245	0.00038	CcSEcCtD
Everolimus—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000244	0.00038	CcSEcCtD
Everolimus—Fatigue—Methotrexate—psoriatic arthritis	0.000244	0.000379	CcSEcCtD
Everolimus—Headache—Betamethasone—psoriatic arthritis	0.000244	0.000378	CcSEcCtD
Everolimus—Headache—Dexamethasone—psoriatic arthritis	0.000244	0.000378	CcSEcCtD
Everolimus—Asthenia—Prednisone—psoriatic arthritis	0.000243	0.000377	CcSEcCtD
Everolimus—Pain—Methotrexate—psoriatic arthritis	0.000242	0.000376	CcSEcCtD
Everolimus—Pruritus—Prednisone—psoriatic arthritis	0.00024	0.000372	CcSEcCtD
Everolimus—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000233	0.000362	CcSEcCtD
Everolimus—Diarrhoea—Prednisone—psoriatic arthritis	0.000232	0.00036	CcSEcCtD
Everolimus—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000231	0.000359	CcSEcCtD
Everolimus—Nausea—Betamethasone—psoriatic arthritis	0.000231	0.000359	CcSEcCtD
Everolimus—Nausea—Dexamethasone—psoriatic arthritis	0.000231	0.000359	CcSEcCtD
Everolimus—Dizziness—Prednisone—psoriatic arthritis	0.000224	0.000348	CcSEcCtD
Everolimus—Body temperature increased—Methotrexate—psoriatic arthritis	0.000224	0.000348	CcSEcCtD
Everolimus—Abdominal pain—Methotrexate—psoriatic arthritis	0.000224	0.000348	CcSEcCtD
Everolimus—Vomiting—Prednisone—psoriatic arthritis	0.000215	0.000334	CcSEcCtD
Everolimus—Rash—Prednisone—psoriatic arthritis	0.000213	0.000332	CcSEcCtD
Everolimus—Dermatitis—Prednisone—psoriatic arthritis	0.000213	0.000331	CcSEcCtD
Everolimus—Headache—Prednisone—psoriatic arthritis	0.000212	0.00033	CcSEcCtD
Everolimus—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000208	0.000324	CcSEcCtD
Everolimus—Asthenia—Methotrexate—psoriatic arthritis	0.000203	0.000315	CcSEcCtD
Everolimus—Nausea—Prednisone—psoriatic arthritis	0.000201	0.000312	CcSEcCtD
Everolimus—Pruritus—Methotrexate—psoriatic arthritis	0.0002	0.000311	CcSEcCtD
Everolimus—Diarrhoea—Methotrexate—psoriatic arthritis	0.000194	0.000301	CcSEcCtD
Everolimus—Dizziness—Methotrexate—psoriatic arthritis	0.000187	0.000291	CcSEcCtD
Everolimus—Vomiting—Methotrexate—psoriatic arthritis	0.00018	0.000279	CcSEcCtD
Everolimus—Rash—Methotrexate—psoriatic arthritis	0.000178	0.000277	CcSEcCtD
Everolimus—Dermatitis—Methotrexate—psoriatic arthritis	0.000178	0.000277	CcSEcCtD
Everolimus—Headache—Methotrexate—psoriatic arthritis	0.000177	0.000275	CcSEcCtD
Everolimus—Nausea—Methotrexate—psoriatic arthritis	0.000168	0.000261	CcSEcCtD
